Navigation Links
Danaher Reports Record Fourth Quarter 2012 Results
Date:1/29/2013

ents speak only as of the date of this release and the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

 DANAHER CORPORATIONRECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES($ in millions except per share data)Forecasted Earnings Per Share GuidanceThree Months Ending
March 29, 2013Year Ending
December 31, 2013Low End

High EndLow End

High EndDiluted Net Earnings Per Share from Continuing Operations (GAAP)$
.94$
.99$
3.54$
3.69Anticipated gain on the sale of investment in
Apex Tool Group LLC in the first quarter of
2013 ($220 million pre-tax for each of the
three and twelve month periods)(0.19)

(0.19)(0.19)

(0.19)Retroactive reinstatement of certain federal tax
provisions contained in the American Tax
Relief Act of 2012.(0.03)

(0.03)(0.03)

(0.03)Adjusted Diluted Net Earnings Per Share from Continuing Operations (Non-GAAP)$
.72$
.77$
3.32$
3.47Core Revenue GrowthComponents of Revenue GrowthThree Months
Ended December
31, 2012  vs. Comparable
2011 PeriodYear Ended
December 31,
2012  vs.
Comparable
2011 PeriodCore (non-GAAP)3.5%

2.5%Acquisitions (non-GAAP)3.0%

13.0%Impact of currency translation (non-GAAP)-1.0%

-2.0%Total Revenue Growth (GAAP)5.5%

13.5%Free Cash FlowYear Ended
December 31, 2012Operating Cash Flow provided by continuing operations (GAAP)$
3,502.1Less: Purchases of Property, Plant & Equipment from continuing operations(458.3)Free Cash Flow (Non-GAAP)$
3,043.8 

Adjusted Diluted Net Earnings Per Share from Continuing OperationsWe disclose the non-GAAP measure of adjusted diluted net earnings per share from continuing operations, which refers to GAAP diluted net earnings per share from continuing operations, exclud
'/>"/>

SOURCE Danaher Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Encision Reports 10% Product Revenue Increase in Third Quarter of Fiscal Year 2013 Results
2. Education and Collaboration Key to Continued Progress in Fighting Rogue Online Prescription Drug Sellers, Reports NABP
3. Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
4. Cepheid Reports Fourth Quarter And Full Year 2012 Results
5. Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
6. Hill-Rom Reports Fiscal First Quarter Results; Updates 2013 Financial Outlook For R&D Tax Credit Reinstatement
7. Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2013
8. MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results
9. Avanir Pharmaceuticals Reports Fiscal 2012 Fourth Quarter And Year-End Financial And Business Results
10. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results
11. Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... , Oct. 30, 2014 China Biologic Products, ... leading fully integrated plasma-based biopharmaceutical company in ... to release third quarter 2014 financial results on Wednesday, ... The Company,s management will hold a conference call ... 2014, which is 8:30 p.m., Beijing Time on November ...
(Date:10/30/2014)... , La fórmula de ... adquirir tolerancia a la proteína de leche de ... la leche de la vaca (APLV) es la principal alergia ... la APLV se trataba eliminando las proteínas lácteas ... es posible adquirir tolerancia oral en un número ...
(Date:10/30/2014)... 2014 The global newborn screening market ... technology, product, and geography. The mass spectrometry market ... in the newborn screening market by technology, during ... to various nations opting for expanded newborn screening. ... for expanded newborn screening. Furthermore, various conferences and ...
Breaking Medicine Technology:China Biologic to Report Third Quarter 2014 Financial Results 2Según expertos reunidos en el Simposio Allergy Day 2Según expertos reunidos en el Simposio Allergy Day 3NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019 2NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019 3
... 11 El Camino Hospital, the hospital of Silicon ... da Vinci® Si HD Surgical Systems. Physicians performed more ... expect the number to increase in 2010 as more ... for more minimally invasive procedures. The new systems feature ...
... BROOMFIELD, Colo., Nov. 11 Accera, Inc., a biotechnology company ... that it will present at Lazard Capital Markets 6th Annual ... in New York. , Steve Orndorff, Ph.D., founder, president ... an update on Axona (TM) on Tuesday, November 17 ...
Cached Medicine Technology:El Camino Hospital Expands Robotic Surgery Program 2El Camino Hospital Expands Robotic Surgery Program 3El Camino Hospital Expands Robotic Surgery Program 4Accera, Inc. To Present at Lazard Capital Markets 6th Annual Healthcare Conference 2
(Date:10/30/2014)... 2014 USARAD Holdings Inc ... and specialty telemedicine solutions provider, including SecondOpinions.com ... existing teleradiology services at Mission Bend ER, it ... telemedicine services, to the state-of-the-art, 24/7, freestanding ER ... of this innovative partnership, there will be many ...
(Date:10/30/2014)... WA (PRWEB) October 30, 2014 Sound Telecom, ... decision infographic that will assist people any time they wonder, ... discover the right answer by leading them through a series ... resolution to their initial query. , There are many considerations ... not to use an answering service . This decision ...
(Date:10/30/2014)... News) -- Many U.S. colleges have indoor tanning ... increases the risk for skin cancer, researchers report. ... white women, so colleges should adopt tanning-free policies, ... "Public health efforts are needed to raise ... harms that indoor tanning poses to young adults ...
(Date:10/30/2014)... 29, 2014) – A new standard of care for ... following a multi-year study published in the latest edition ... , The research, led by John Wagner, Jr., M.D., ... at the University of Minnesota and a researcher in ... in children with acute leukemia and myelodysplastic syndrome who ...
(Date:10/28/2014)... and outer body and organ surfaces in the human ... in the inner ear," said Moritz Gegg. Cilia – ... are precisely positioned on many of these epithelial cells. ... coordinated so precisely that for example mucus can be ... from sensory inner ear hair cells," added Heiko Lickert. ...
Breaking Medicine News(10 mins):Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 2Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 3Health News:Sound Telecom Produces Decision Infographic to Aid Businesses 2Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2Health News:Survival rates in pediatric umbilical cord transplants may indicate a new standard of care 2Health News:Survival rates in pediatric umbilical cord transplants may indicate a new standard of care 3Health News:New insights into the development of ciliopathies 2
... the seventh leading cause of cancer death worldwide, the ... group and gender. Esophageal cancer is thought to be ... with the host genome. Researchers have long been seeking ... conducted on gene-environment interaction and gene polymorphisms for esophageal ...
... intellectual property laws devalue the "repurposing" of existing ... life-saving treatments, a Portland researcher contends. , S. ... behavioral neuroscience in the Oregon Health & Science ... Affairs Medical Center, writes in a letter appearing ...
... Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ), today ... Pharmaceuticals GmbH (Merz) for sales,by Merz and its ... severe Alzheimer,s disease for the quarter ended June ... royalty payments compared to,the same quarter last year, ...
... Oct. 31 MAP,Pharmaceuticals, Inc. (Nasdaq: ... the initiation of a Phase 2a clinical ... asthma and chronic obstructive,pulmonary disease (COPD). ... and a long-acting,beta2-agonist delivered to the respiratory ...
... and Offshore Healthcare Expertise and ... Service Delivery Capabilities EL SEGUNDO, Calif. ... CSC ) and,First Consulting Group, Inc. (Nasdaq: FCGI ) today ... through which CSC will acquire,First Consulting Group (FCG) in an all-cash ...
... EDMONTON, Oct. 31 /PRNewswire-FirstCall/ - BioMS Medical Corp ... multiple sclerosis (MS), today,announced that Mr. Kevin Giese, ... Rodman and Renshaw 9th Annual Healthcare Conference in ... 3:20 pm (Local Time), WHERE: New York ...
Cached Medicine News:Health News:ADH2 and ALDH2 are associated with esophageal cancer 2Health News:Old drugs need 'repurposing' for new uses, physician says 2Health News:MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma 2Health News:MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma 3Health News:MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma 4Health News:CSC Agrees to Acquire First Consulting Group 2Health News:CSC Agrees to Acquire First Consulting Group 3Health News:CSC Agrees to Acquire First Consulting Group 4Health News:CSC Agrees to Acquire First Consulting Group 5Health News:BioMS Medical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2
... Millipore has developed a range of ... match specific water quality requirements. Each ... is designed to specifically target contaminants ... HPLC, molecular biology and ICP-MS. The ...
Inquire...
... the Mo Bio Vortex Adapter in conjunction with ... procedures. Using the Mo Bio Vortex Adapter ... and Fast Prep machines which offer the same ... ml) centrifuge tubes at one time and will ...
... Combines BchiVac V-500 with Vacuum ... Efficiently controls vacuum levels from ... pump designed to handle most vacuum applications. ... up to two rotary evaporators Laboratory ...
Medicine Products: